论文部分内容阅读
皮肌炎(DM)与多发性肌炎(PM)同属一组以特发性炎症性肌病为特征的自身免疫性结缔组织病,临床表现为四肢近端肌肉受累,可累及皮肤、肺部、消化道、心脏等。本研究探讨1例DM合并医院获得性肺炎患者的用药分析和药学监护。临床药师协助医师制定治疗方案,开展药学监护,参与临床诊疗,可提高合理用药水平,改善患者预后。因此临床药师要利用自身优势,参与到诊疗活动中,开展全面的药学监护,保障患者用药安全。
Dermatomyositis (DM) and polymyositis (PM) belong to the same group of idiopathic inflammatory myopathies characterized by autoimmune connective tissue disease, the clinical manifestations of proximal limb muscle involvement, can affect the skin, lungs , Digestive tract, heart and so on. This study was to investigate the medication analysis and pharmacy care of 1 DM with hospital-acquired pneumonia. Clinical pharmacists to assist physicians in the development of treatment programs, carry out pharmacy care, participate in clinical diagnosis and treatment, can improve the reasonable level of medication, improve patient prognosis. Therefore, clinical pharmacists to take advantage of their own advantages, to participate in the diagnosis and treatment activities, to carry out a comprehensive pharmacy care to protect the safety of patients medication.